Enhancement of pomalidomide anti-tumor response with ACY-241, a selective HDAC6 inhibitor

por North, Brian J., Almeciga-Pinto, Ingrid, Tamang, David, Yang, Min, Jones, Simon S., Quayle, Steven N.
Publicado 2017

Selective HDAC inhibition by ACY-241 enhances the activity of paclitaxel in solid tumor models

por Huang, Pengyu, Almeciga-Pinto, Ingrid, Jarpe, Matthew, van Duzer, John H, Mazitschek, Ralph, Yang, Min, Jones, Simon S, Quayle, Steven N
Publicado 2016

HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model

por Maharaj, Kamira, Powers, John J., Mediavilla-Varela, Melanie, Achille, Alex, Gamal, Wael, Quayle, Steven, Jones, Simon S., Sahakian, Eva, Pinilla-Ibarz, Javier
Publicado 2020

Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia

por Min, Chengyin, Moore, Nathan, Shearstone, Jeffrey R., Quayle, Steven N., Huang, Pengyu, van Duzer, John H., Jarpe, Matthew B., Jones, Simon S., Yang, Min
Publicado 2017

Novel expressed sequences identified in a model of androgen independent prostate cancer

por Quayle, Steven N, Hare, Heidi, Delaney, Allen D, Hirst, Martin, Hwang, Dorothy, Schein, Jacqueline E, Jones, Steven JM, Marra, Marco A, Sadar, Marianne D
Publicado 2007

HDAC1,2 inhibition impairs EZH2- and BBAP- mediated DNA repair to overcome chemoresistance in EZH2 gain-of-function mutant diffuse large B-cell lymphoma

por Johnson, Danielle P., Spitz, Gabriella S., Tharkar, Shweta, Quayle, Steven N., Shearstone, Jeffrey R., Jones, Simon, McDowell, Maria E., Wellman, Hannah, Tyler, Jessica K., Cairns, Bradley R., Chandrasekharan, Mahesh B., Bhaskara, Srividya
Publicado 2014

Integrative functional genomics identifies RINT1 as a novel GBM oncogene

por Quayle, Steven N., Chheda, Milan G., Shukla, Sachet A., Wiedemeyer, Ruprecht, Tamayo, Pablo, Dewan, Robert W., Zhuang, Li, Huang-Hobbs, Emmet, Haidar, Sam, Xiao, Yonghong, Ligon, Keith L., Hahn, William C., Chin, Lynda
Publicado 2012

Somatic Mutations of PIK3R1 Promote Gliomagenesis

por Quayle, Steven N., Lee, Jennifer Y., Cheung, Lydia W T., Ding, Li, Wiedemeyer, Ruprecht, Dewan, Robert W., Huang-Hobbs, Emmet, Zhuang, Li, Wilson, Richard K., Ligon, Keith L., Mills, Gordon B., Cantley, Lewis C., Chin, Lynda
Publicado 2012

Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells

por Seidel, Ronald D., Merazga, Zohra, Thapa, Dharma Raj, Soriano, Jonathan, Spaulding, Emily, Vakkasoglu, Ahmet S., Ruthardt, Paige, Bautista, Wynona, Quayle, Steven N., Kiener, Peter A., Low, Simon, Ross, John F., Cemerski, Saso, Suri, Anish, Almo, Steven C., Chaparro, Rodolfo J.
Publicado 2021

HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers

por Putcha, Preeti, Yu, Jiyang, Rodriguez-Barrueco, Ruth, Saucedo-Cuevas, Laura, Villagrasa, Patricia, Murga-Penas, Eva, Quayle, Steven N., Yang, Min, Castro, Veronica, Llobet-Navas, David, Birnbaum, Daniel, Finetti, Pascal, Woodward, Wendy A., Bertucci, François, Alpaugh, Mary L., Califano, Andrea, Silva, Jose
Publicado 2015

Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers

por Putcha, Preeti, Yu, Jiyang, Rodriguez-Barrueco, Ruth, Saucedo-Cuevas, Laura, Villagrasa, Patricia, Murga-Penas, Eva, Quayle, Steven N., Yang, Min, Castro, Veronica, Llobet-Navas, David, Birnbaum, Daniel, Finetti, Pascal, Woodward, Wendy A., Bertucci, François, Alpaugh, Mary L., Califano, Andrea, Silva, Jose
Publicado 2017